Sandrock Alfred, CEO of Voyager Therapeutics VYGR, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $184.4K. The latest trade was on 04/02.

SA

SA

Sandrock Alfred

President and CEO

Company

Voyager Therapeutics VYGR

First filing

23/02/22

Trades

18 trades

Buys / sales

0 / 10

12-month net buying

−$184.4K

Last trade

04/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Voyager TherapeuticsVYGR	Open-market sale10b5-1 plan	04/02	04/03	11,511 sh	$3.87	$44,547.57	−2.4%
Voyager TherapeuticsVYGR	Open-market sale10b5-1 plan	02/24	02/26	14,197 sh	$3.79	$53,806.63	−2.8%
Voyager TherapeuticsVYGR	Open-market sale10b5-1 plan	02/18	02/20	11,732 sh	$3.41	$40,006.12	−2.3%
Voyager TherapeuticsVYGR	Open-market sale	02/10	02/11	12,192 sh	$3.78	$46,085.76	−2.3%
Voyager TherapeuticsVYGR	Open-market sale	25/04/02	25/04/04	10,885 sh	$3.43	$37,335.55	−2.5%
Voyager TherapeuticsVYGR	Open-market sale	25/02/20	25/02/24	11,702 sh	$4.24	$49,616.48	−3.8%
Voyager TherapeuticsVYGR	Open-market sale	25/02/11	25/02/12	16,644 sh	$4.45	$74,065.8	−5.1%
Voyager TherapeuticsVYGR	Open-market sale	24/04/02	24/04/03	12,115 sh	$9.86	$119,453.9	−3.6%
Voyager TherapeuticsVYGR	Open-market sale	24/02/21	24/02/22	13,033 sh	$7.46	$97,226.18	−3.7%
Voyager TherapeuticsVYGR	Open-market sale	23/04/03	23/04/05	7,437 sh	$7.83	$58,231.71	−3.3%